Skip to main content

lamotrigine

Generic: LAMOTRIGINE·Brand: LAMICTAL, LAMICTAL CD, LAMICTAL ODT, LAMICTAL XR, LAMOTRIGINE, Lamictal, SUBVENITE, Subvenite

lamotrigine: 2 clinical trials tracked.

lamotrigine evidence translation

What we can confirm

2 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about lamotrigine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

Healthy Volunteers
Clinical Trials (2)

A Phase 3, Open-label Extension Study to Assess the Long-term Safety of KarXT for the Treatment of Mania or Mania With Mixed Features in Bipolar-I Disorder (BALSAM-3)

NCT06929273·Phase 3·BMY
Recruiting

Primary endpoint: Number of participants with treatment emergent adverse events (TEAEs)

Interventionalopen450 targetStarted 2025-07Completion 2028-0650 sites · United StatesBristol-Myers Squibb

A Phase 1, 6-part, Open-label, Fixed-sequence Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Single-dose Pharmacokinetics of KarXT and Effects of KarXT on the Single-dose Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participants

NCT06729970·Phase 1·BMY
Completed

Primary endpoint: Maximum observed plasma concentration (Cmax)

Interventionalopen133 enrolledStarted 2024-12Completion 2026-011 site · United StatesKaruna Therapeutics